Despite the favorable prognosis observed in transplanted patients, there are still some concerns and long-term complications since the previously existing hereditary amyloid deposits may recruit newly circulating TTR wt promoting amyloid growth and, ultimately resulting in disease progression (Maurer et al., 2016; Saelices et al., 2018). The gene discussed is TTR; the disease is amyloidosis.